Identifying surrogate markers in real‐world comparative effectiveness research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identifying surrogate markers in real‐world comparative effectiveness research

Published:2022-09-05 Issue:26 Volume:41 Page:5290-5304
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Han Larry¹^ORCID,Wang Xuan¹,Cai Tianxi¹

Affiliation:

1. Department of Biostatistics Harvard T.H. Chan School of Public Health Boston Massachusetts

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9569

Reference51 articles.

1. Biomarkers and surrogate endpoints in clinical trials

2. Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward

3. Biomarkers and Surrogate Endpoints in Drug Development: A European Regulatory View

4. The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018

5. Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flexible evaluation of surrogate markers with Bayesian model averaging;Statistics in Medicine;2023-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP